Author:
Yi Xiong-xiong,Zhang Wen-rong,Wang Dong-mei,Wang Xiu-ping,Zhang Fen-xia
Abstract
This study examines research perspective in the clinical diagnosis, treatment, and prevention of cardiovascular complications in Kawasaki Disease (KD). Starting with an overview of the disease, it introduces KD's clinical manifestations, etiology, epidemiological features, and its impact on the cardiovascular system. Subsequently, the study discusses in detail the diagnostic methods, pathological mechanisms, and treatment strategies for KD, including foundational and emerging approaches such as high-dose intravenous immunoglobulin and aspirin therapy, biologic therapy, and corticosteroid pulse therapy. Additionally, it outlines strategies for preventing cardiovascular complications, including early risk assessment and long-term management. The study also explores the intersection of the COVID-19 pandemic with an increase in KD-like symptoms, emphasizing the need for further studies on the association between SARS-CoV-2 and KD. Lastly, it explores future research directions to enhance understanding of KD and improve patient outcomes and quality of life. This study provides valuable insights into the comprehensive treatment and management of KD and highlights avenues for future research.
Reference51 articles.
1. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American heart association;Newburger;Circulation,2004
2. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association;McCrindle;Circulation,2017
3. Kawasaki disease: a brief history;Burns;Pediatrics,2000
4. The epidemiology and pathogenesis of Kawasaki disease;Rowley;Front Pediatr,2018
5. Epidemiology of Kawasaki disease in Asia, Europe, and the United States;Uehara;J Epidemiol,2012